Myriad Receives FDA Approval of myChoice CDx® as Companion Diagn

做多

Myriad Genetics, Inc. (NASDAQ:MYGN)

NASDAQ:MYGN Myriad Genetics, Inc.

beyondta

MYGN: Myriad Genetics, Inc.
2020-05-11 07:05:10
Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。